Heterologous immunization with improved HIV1 subtype C vaccines elicit Tier 2 neutralizing antibodies with rapid viral replication control after SHIV challenge - G Chege; R Chapman; A Keyser; C Adams; Bronwen Lambson; Tandile Hermanus; Penelope Moore; " "et al" (My University, 2025)